Selitrectinib is an investigational, oral, next-generation, highly selective TRK kinase inhibitor, specifically designed to overcome acquired resistance to prior TRK inhibitor therapy, particularly th…
Repotrectinib is an oral, next-generation, macrocyclic tyrosine kinase inhibitor designed to potently inhibit ROS1 and TRK kinases, particularly effective against solvent-front mutations that cause re…
Ensartinib is an oral, potent, and highly selective second-generation inhibitor of anaplastic lymphoma kinase (ALK), developed to overcome resistance and improve efficacy against central nervous syste…
Crizotinib is an oral, first-in-class, small-molecule inhibitor of anaplastic lymphoma kinase (ALK), ROS1, and MET tyrosine kinases, primarily used to treat ALK-positive or ROS1-positive non-small cel…
Desmopressin Acetate is a synthetic analogue of the natural pituitary hormone vasopressin (antidiuretic hormone, ADH). It is primarily known for its potent and prolonged …
Hangzhou Jinlan Pharm-Drugs Technology Co., Ltd. (JL Pharm) is established in 2012 at the beautiful West Lake – Hangzhou city, China. The company's main business includes R&D, Produ…
ECROBOT CO., Ltd, Business Registration Number : 220-88-71747, CEO J.W.Park, TEL : +82-2-552-7676, E-mail : E-mail : Contact us Address : (Hwanghwa B/D 11F, Yeoksam-dong)320, Gangnam-daero, Gangnam-gu, Seoul, South Korea